Publication | Closed Access

Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II

Genetic DisorderMedicineGlycogen Storage DiseaseInherited Metabolic DiseaseGenetic EpidemiologyPathologyDisease Gene IdentificationMolecular DiagnosticsType IiGaa Mutation Spectrum